Metabolic biomarkers for predicting cardiovascular disease

References

• MensahGABrownDWAn overview of cardiovascular disease burden in the United StatesHealth Aff (Millwood)2007261384817211012
   PubMed Web of Science ®Google Scholar
• Lloyd-JonesDMLarsonMGBeiserALevyDLifetime risk of developing coronary heart diseaseLancet19993539147899210023892
   PubMed Web of Science ®Google Scholar
• National Heart L, and Blood InstituteFY 2011 Fact Book2011 Available from: http://www.nhlbi.nih.gov/about/factbook/FactBook2011.pdfAccessed August 24, 2012
   Google Scholar
• HlatkyMAGreenlandPArnettDKCriteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart AssociationCirculation2009119172408241619364974
   PubMedGoogle Scholar
• VasanRSBiomarkers of cardiovascular disease: molecular basis and practical considerationsCirculation2006113192335236216702488
   PubMed Web of Science ®Google Scholar
• Biomarkers and surrogate endpoints: preferred definitions and conceptual frameworkClin Pharmacol Ther2001693899511240971
   PubMed Web of Science ®Google Scholar
• KannelWBDawberTRKaganARevotskieNStokesJ3rdFactors of risk in the development of coronary heart disease – six year follow-up experience. The Framingham StudyAnn Intern Med196155335013751193
   PubMed Web of Science ®Google Scholar
• StampferMJRidkerPMDzauVJRisk factor criteriaCirculation200410925 Suppl 1IV3515226245
   PubMed Web of Science ®Google Scholar
• WilkinsJTLloyd-JonesDMBiomarkers for coronary heart disease clinical risk prediction: a critical appraisal. CounterpointPrev Cardiol201013416016520860638
   PubMedGoogle Scholar
• PencinaMJD’AgostinoRBSrD’AgostinoRBJrVasanRSEvaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyondStat Med2008272157172 discussion 207–21217569110
   PubMed Web of Science ®Google Scholar
• ShahTCasasJPCooperJACritical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohortsInt J Epidemiol200938121723118930961
   PubMed Web of Science ®Google Scholar
• GreenlandPAlpertJSBellerGA2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice GuidelinesCirculation2010122252748276421098427
   PubMed Web of Science ®Google Scholar
• WilsonPWChallenges to improve coronary heart disease risk assessmentJAMA2009302212369237019952326
   PubMed Web of Science ®Google Scholar
• WangTJGonaPLarsonMGMultiple biomarkers for the prediction of first major cardiovascular events and deathN Engl J Med2006355252631263917182988
   PubMed Web of Science ®Google Scholar
• KavousiMElias-SmaleSRuttenJHEvaluation of newer risk markers for coronary heart disease risk classification: a cohort studyAnn Intern Med2012156643844422431676
   PubMed Web of Science ®Google Scholar
• FolsomARChamblessLEBallantyneCMAn assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities studyArch Intern Med2006166131368137316832001
   PubMed Web of Science ®Google Scholar
• ReichlinTSchindlerCDrexlerBOne-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin TArch Intern Med2012172161211121822892889
   PubMedGoogle Scholar
• NadirMARekhrajSWeiLImproving the primary prevention of cardiovascular events by using biomarkers to identify individuals with silent heart diseaseJ Am Coll Cardiol2012601196096822921971
   PubMed Web of Science ®Google Scholar
• GreenlandPKnollMDStamlerJMajor risk factors as antecedents of fatal and nonfatal coronary heart disease eventsJAMA2003290789189712928465
   PubMed Web of Science ®Google Scholar
• KhotUNKhotMBBajzerCTPrevalence of conventional risk factors in patients with coronary heart diseaseJAMA2003290789890412928466
   PubMed Web of Science ®Google Scholar
• PtolemyASRifaiNWhat is a biomarker? Research investments and lack of clinical integration necessitate a review of biomarker terminology and validation schemaScand J Clin Lab Invest Suppl201024261420515269
   PubMedGoogle Scholar
• PalazzuoliAIovineFGallottaMNutiREmerging cardiac markers in coronary disease: role of brain natriuretic peptide and other biomarkersMinerva Cardioangiol200755449149617653025
   PubMedGoogle Scholar
• RanaJSGransarHWongNDComparative value of coronary artery calcium and multiple blood biomarkers for prognostication of cardiovascular eventsAm J Cardiol2012109101449145322425333
   PubMed Web of Science ®Google Scholar
• DongBJiWZhangYElevated serum chemerin levels are associated with the presence of coronary artery disease in patients with metabolic syndromeIntern Med201150101093109721576834
   PubMed Web of Science ®Google Scholar
• WangJHLeeCJLeeCCChenYCLeeRPHsuBGFasting adiponectin is inversely correlated with metabolic syndrome in patients with coronary artery diseaseIntern Med201049873974720424363
   PubMed Web of Science ®Google Scholar
• SaelyCHVonbankAReinPAlanine aminotransferase and gamma-glutamyl transferase are associated with the metabolic syndrome but not with angiographically determined coronary atherosclerosisClin Chim Acta20083971–2828618708042
   PubMed Web of Science ®Google Scholar
• YanoYToshinaiKInokuchiTPlasma des-acyl ghrelin, but not plasma HMW adiponectin, is a useful cardiometabolic marker for predicting atherosclerosis in elderly hypertensive patientsAtherosclerosis2009204259059419041092
   PubMed Web of Science ®Google Scholar
• TzotzasTDesrumauxCLagrostLPlasma phospholipid transfer protein (PLTP): review of an emerging cardiometabolic risk factorObesity Rev2009104403411
   PubMed Web of Science ®Google Scholar
• GopaulKPCrookMASialic acid: a novel marker of cardiovascular disease?Clin Biochem200639766768116624269
   PubMed Web of Science ®Google Scholar
• MarianAJNambiVBiomarkers of cardiac diseaseExp Rev Mol Diagn200446805820
   PubMed Web of Science ®Google Scholar
• ReynoldsRMIlyasBPriceJFCirculating plasma cortisol concentrations are not associated with coronary artery disease or peripheral vascular diseaseQJM2009102746947519458201
   PubMed Web of Science ®Google Scholar
• KoenigWUpdate on integrated biomarkers for assessment of long-term risk of cardiovascular complications in initially healthy subjects and patients with manifest atherosclerosisAnn Med200941533234319291518
   PubMed Web of Science ®Google Scholar
• ShlipakMGIxJHBibbins-DomingoKLinFWhooleyMABiomarkers to predict recurrent cardiovascular disease: the Heart and Soul StudyAm J Med20081211505718187073
   PubMed Web of Science ®Google Scholar
• TillettWSFrancisTSerological reactions in pneumonia with a non-protein somatic fraction of PneumococcusJ Exper Med193052456157119869788
   PubMedGoogle Scholar
• BassukSSRifaiNRidkerPMHigh-sensitivity C-reactive protein: clinical importanceCurr Probl Cardiol200429843949315258556
   PubMed Web of Science ®Google Scholar
• ZwakaTPHombachVTorzewskiJC-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosisCirculation200110391194119711238260
   PubMed Web of Science ®Google Scholar
• PasceriVWillersonJTYehETDirect proinflammatory effect of C-reactive protein on human endothelial cellsCirculation2000102182165216811056086
   PubMed Web of Science ®Google Scholar
• JaffeASBabuinLAppleFSBiomarkers in acute cardiac disease: the present and the futureJ Am Coll Cardiol200648111116814641
   PubMed Web of Science ®Google Scholar
• PradhanADMansonJERossouwJEInflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women’s Health Initiative observational studyJAMA2002288898098712190368
   PubMed Web of Science ®Google Scholar
• RidkerPMCushmanMStampferMJTracyRPHennekensCHInflammation, aspirin, and the risk of cardiovascular disease in apparently healthy menN Engl J Med1997336149739799077376
   PubMed Web of Science ®Google Scholar
• CannonCPSteinbergBAEvidence-Based CardiologyPhiladelphia, PAWolters Kluwer2011
   Google Scholar
• RidkerPMRifaiNRoseLBuringJECookNRComparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular eventsN Engl J Med2002347201557156512432042
   PubMed Web of Science ®Google Scholar
• DupuisJTardifJCRouleauJLCannonCPIntensity of lipid lowering with statin and brachial artery vascular endothelium reactivity after acute coronary syndromesAm J Cardiol20051119691207121316253583
   PubMed Web of Science ®Google Scholar
• NissenSETuzcuEMSchoenhagenPEffect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trialJAMA200429191071108014996776
   PubMed Web of Science ®Google Scholar
• RidkerPMRifaiNClearfieldMMeasurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary eventsN Engl J Med2001344261959196511430324
   PubMed Web of Science ®Google Scholar
• RidkerPMDanielsonEFonsecaFARosuvastatin to prevent vascular events in men and women with elevated C-reactive proteinN Engl J Med2008359212195220718997196
   PubMed Web of Science ®Google Scholar
• HaverkateFThompsonSGPykeSDGallimoreJRPepysMBProduction of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study GroupLancet199734990504624669040576
   PubMed Web of Science ®Google Scholar
• TsimikasSWillersonJTRidkerPMC-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patientsJ Am Coll Cardiol200647Suppl 8C19C3116631506
   PubMed Web of Science ®Google Scholar
• MilazzoDBiasucciLMLucianiNElevated levels of C-reactive protein before coronary artery bypass grafting predict recurrence of ischemic eventsAm J Cardiol1999844459461A45910468087
   PubMed Web of Science ®Google Scholar
• RidkerPMRifaiNPfefferMAInflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) InvestigatorsCirculation19989898398449738637
   PubMed Web of Science ®Google Scholar
• MuellerCBuettnerHJHodgsonJMInflammation and long-term mortality after non-ST elevation acute coronary syndrome treated with a very early invasive strategy in 1042 consecutive patientsCirculation2002105121412141511914246
   PubMed Web of Science ®Google Scholar
• WensleyFGaoPBurgessSAssociation between C-reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant dataBMJ2011342d54821325005
   PubMedGoogle Scholar
• ElliottPChambersJCZhangWGenetic loci associated with C-reactive protein levels and risk of coronary heart diseaseJAMA20093021374819567438
   PubMed Web of Science ®Google Scholar
• CookNRBuringJERidkerPMThe effect of including C-reactive protein in cardiovascular risk prediction models for womenAnn Intern Med20061451212916818925
   PubMed Web of Science ®Google Scholar
• BuckleyDIFuRFreemanMRogersKHelfandMC-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the US Preventive Services Task ForceAnn Intern Med2009151748349519805771
   PubMed Web of Science ®Google Scholar
• KonstantinoYWolkRTerraSGNguyenTTFryburgDANon-traditional biomarkers of atherosclerosis in stable and unstable coronary artery disease, do they differ?Acute Cardiac Care20079419720617924231
   PubMedGoogle Scholar
• MichaRImamuraFWyler von BallmoosMSystematic review and meta-analysis of methotrexate use and risk of cardiovascular diseaseAm J Cardiol201110891362137021855836
   PubMed Web of Science ®Google Scholar
• AlbertMABiomarkers and heart diseaseJ Clin Sleep Med20117Suppl 5S9S1122003335
   PubMed Web of Science ®Google Scholar
• Disease CoQoBaSEiC, Medicine IoEvaluation of Biomarkers and Surrogate Endpoints in Chronic DiseaseWashington, DCNational Academies Press2010
   Google Scholar
• KimHCClinical utility of novel biomarkers in the prediction of coronary heart diseaseKorean Circ J201242422322822563333
   PubMed Web of Science ®Google Scholar
• National Heart Lung, and Blood InstituteFY 2011 Fact Book2011 Available from: http://www.nhlbi.nih.gov/about/factbook/FactBook2011.pdfAccessed August 24, 2012
   Google Scholar
• GargAWhat is the role of alternative biomarkers for coronary heart disease?Clinical endocrinology9201175328929321521314
   PubMed Web of Science ®Google Scholar
• HerderCKarakasMKoenigWBiomarkers for the prediction of type 2 diabetes and cardiovascular diseaseClin Pharmacol Ther2011901526621654741
   PubMed Web of Science ®Google Scholar
• ShlipakMGFriedLFCushmanMManolioTAPetersonDStehman-BreenCBleyerANewmanASiscovickDPsatyBCardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factorsJAMA2005293141737174515827312
   PubMed Web of Science ®Google Scholar
• WangTJGonaPLarsonMGMultiple biomarkers for the prediction of first major cardiovascular events and deathN Engl J Med2006355252631263917182988
   PubMed Web of Science ®Google Scholar
• FolsomARChamblessLEBallantyneCMAn assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities studyArch Intern Med2006166131368137316832001
   PubMed Web of Science ®Google Scholar
• ZetheliusBBerglundLSundströmJUse of multiple biomarkers to improve the prediction of death from cardiovascular causesN Engl J Med2008358202107211618480203
   PubMed Web of Science ®Google Scholar
• MelanderONewton-ChehCAlmgrenPNovel and conventional biomarkers for prediction of incident cardiovascular events in the communityJAMA20093021495719567439
   PubMed Web of Science ®Google Scholar
• BlankenbergSZellerTSaarelaOMORGAM ProjectContribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, risk, genetics, archiving, and monograph (MORGAM) biomarker projectCirculation2010121222388239720497981
   PubMed Web of Science ®Google Scholar
• SattarNMurrayHMWelshPProspective Study of Pravastatin in the Elderly at Risk (PROSPER) Study GroupAre markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events?PLoS Med200923;66e1000099
   Web of Science ®Google Scholar
• de RuijterWWestendorpRGAssendelftWJUse of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort studyBMJ2009338a3083.7319131384
   PubMedGoogle Scholar
• SchnabelRBSchulzAMessowCMMultiple marker approach to risk stratification in patients with stable coronary artery diseaseEur Heart J201031243024303120852293
   PubMed Web of Science ®Google Scholar
• HerderCBaumertJZiererAImmunological and cardiometabolic risk factors in the prediction of type 2 diabetes and coronary events: MONICA/KORA Augsburg case-cohort studyPLoS One201166e1985221674000
   PubMed Web of Science ®Google Scholar